MARKET RASEN SURGERY — All Prescriptions & Medications — Page 11
Practice Code: C83043 | MARKET RASEN, LN8 3BP
Showing results 501-550 of 696
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 31 | 1,010 | £2.0K | +51.2% ▲ | |
| 31 | 965 | £2.7K | +66.1% ▲ | |
| Trihexyphenidyl hydrochloride | 30 | 1,568 | £117 | +5.8% ▲ |
| Rifaximin | 30 | 1,110 | £4.6K | +11.7% ▲ |
| Azelastine hydrochloride | 30 | 660 | £290 | +167.7% ▲ |
| Zinc oxide | 29 | 733 | £85 | +40.2% ▲ |
| Oxcarbazepine | 29 | 2,932 | £1.4K | +3.7% ▲ |
| Oxytetracycline | 29 | 3,164 | £1.2K | +12.3% ▲ |
| Betamethasone sodium phosphate | 29 | 310 | £65 | +11.9% ▲ |
| Sodium chloride | 29 | 1,769 | £1.1K | -2.5% ▼ |
| Co-tenidone (Atenolol/chlortalidone) | 28 | 784 | £136 | +34.3% ▲ |
| Citalopram hydrochloride | 28 | 420 | £297 | +74.4% ▲ |
| Methenamine hippurate | 28 | 1,680 | £434 | -69.2% ▼ |
| Cabergoline | 28 | 584 | £1.2K | +80.6% ▲ |
| Diclofenac sodium | 28 | 1,400 | £977 | +16.8% ▲ |
| 28 | 350 | £1.8K | +225.6% ▲ | |
| Co-amilozide (Amiloride hydrochloride/hydrochlorothiazide) | 27 | 1,120 | £519 | +65.1% ▲ |
| INR blood testing reagents | 27 | 1,248 | £3.4K | +258.3% ▲ |
| Codeine phosphate | 27 | 7,200 | £363 | +88.1% ▲ |
| Fosfomycin trometamol | 27 | 38 | £168 | -5.1% ▼ |
| Fluorometholone | 27 | 210 | £67 | +87.4% ▲ |
| Mupirocin | 27 | 525 | £177 | +190.8% ▲ |
| 27 | 1,453 | £324 | +301.0% ▲ | |
| 27 | 3,200 | £317 | -44.0% ▼ | |
| Glycopyrronium bromide | 26 | 7,800 | £5.3K | +26.6% ▲ |
| Losartan potassium with diuretic | 26 | 728 | £110 | +1.4% vs avg |
| Pyridostigmine bromide | 26 | 5,150 | £478 | +51.9% ▲ |
| 26 | 720 | £3.5K | +105.5% ▲ | |
| Glucagon | 25 | 25 | £265 | +64.3% ▲ |
| Emollient bath and shower preparations | 25 | 10.1K | £128 | -60.2% ▼ |
| 25 | 12.5K | £124 | -72.6% ▼ | |
| 25 | 161 | £326 | +51.5% ▲ | |
| 25 | 740 | £3.6K | +103.9% ▲ | |
| Timolol | 24 | 720 | £1.3K | +8.3% ▲ |
| Glycopyrronium/formoterol | 24 | 25 | £750 | -5.1% ▼ |
| Alprostadil | 24 | 113 | £1.3K | +40.3% ▲ |
| Dantrolene sodium | 24 | 5,484 | £880 | +33.1% ▲ |
| Tafluprost and timolol | 24 | 720 | £329 | +25.0% ▲ |
| Betamethasone esters | 24 | 2,010 | £173 | -60.2% ▼ |
| 24 | 294 | £953 | -45.4% ▼ | |
| 24 | 800 | £3.4K | +283.8% ▲ | |
| Valsartan with diuretic | 23 | 644 | £329 | +73.6% ▲ |
| Desloratadine | 23 | 970 | £84 | -20.3% ▼ |
| Acamprosate calcium | 23 | 3,654 | £412 | -34.0% ▼ |
| Testosterone undecanoate | 23 | 23 | £1.8K | -9.4% ▼ |
| 23 | 260 | £713 | +12.6% ▲ | |
| 23 | 850 | £969 | +12.9% ▲ | |
| Inclisiran | 22 | 22 | £987 | +74.6% ▲ |
| Calcium carbonate | 22 | 1,535 | £129 | -66.6% ▼ |
| Sodium fluoride | 22 | 1,338 | £84 | -33.7% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.